A Novel Gene, FGA7, Is Fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a Patient with T-Cell Acute Lymphoblastic Leukemia

Genes Chromosomes and Cancer

Volumn 39, Issue 2, 2004, Pages 110-118

  Mikhail, Fady M ^a,b   Coignet, Lionel ^c   Hatem, Nadia ^a   Mourad, Zeinab I ^a   Farawela, Hala M ^d   El Kaffash, Dalal M ^a   Farahat, Nahla ^a   Nucifora, Giuseppina ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; COMPLEMENTARY DNA; CORE BINDING FACTOR; GENE PRODUCT; PROTEIN FGA7; RNA; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; AML1 GENE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CASE REPORT; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 4; CONTROLLED STUDY; DNA SEQUENCE; EXON; EXPRESSED SEQUENCE TAG; FGA7 GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE FUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNX1 GENE; SEQUENCE HOMOLOGY; T CELL LEUKEMIA; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 4; CLONING, MOLECULAR; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, T-CELL, ACUTE; MICE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; RATS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 0347357871     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10302     Document Type: Article

References (37)

1. Cherry AM, Bangs CD, Jones P, Hall S, Natkunam Y. 2001. A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia. Cancer Genet Cytogenet 129:155-160.
2. Dong JT. 2001. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 20:173-193.
3. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M. 1998. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91:4028-4037.
4. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-21.
5. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG. 1995. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol 15:5830-5845.
6. Hromas R, Shopnick R, Jumean HG, Bowers C, Varella-Garcia M, Richkind K. 2000. A novel syndrome of radiation-induced acute myeloid leukemia involving AML1 gene translocations. Blood 95:4011-4013.
7. Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y. 2001. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 20:723-33.
8. Izumi T, Ohtsuki T, Ohya K, Ogawa Y, Yoshida M, Muroi K, Imagawa S, Hatake K, Kuriki K, Saito K, Miura Y. 1996. Therapy-related leukemia with a novel 21q22 rearrangement. Cancer Genet Cytogenet 90:45-48.
9. Kere J, Ruutu T, de la Chapelle A. 1987. Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. N Engl J Med 316:499-503.
10. Levanon D, Glusman G, Bangsow T, Ben-Asher E, Male DA, Avidan N, Bangsow C, Hattori M, Taylor TD, Taudien S, Blechschmidt K, Shimizu N, Rosenthal A, Sakaki Y, Lancet D, Groner Y. 2001. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene 262:23-33.
11. Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L. 1998. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA 95:3781-3785.
12. Mathew S, Head D, Rubnitz JE, Raimondi SC. 2000. Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia. Genes Chromosomes Cancer 28:227-232.
13. Meyers S, Downing JR, Hiebert SW. 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13:6336-345.
14. Mikhail FM, Serry KA, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM, Coignet L, Nucifora G. 2002. A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 135:96-100.
15. Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 transcript. EMBO J 12:2715-21.
16. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD. 1994. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol 14:5558-5568.
17. Nucifora G, Rowley JD. 1995. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14.
18. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD. 1994. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in t(3; 21)(q26;q22) translocations. Proc Natl Acad Sci USA 91:4004-4008.
19. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K. 1993. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194: 314-331.
20. Paulien S, Maarek O, Daniel MT, Berger R. 2002. A novel translocation, t(9;21)(q13;q22) rearranging the RUNX1 gene in acute myelomonocytic leukemia. Ann Genet 45:67-69.
21. Pedersen-Bjergaard J, Timshel S, Andersen MK, Andersen AS, Philip P. 1998. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes Chromosomes Cancer 23:337-349.
22. Redondo JM, Pfohl JL, Hernandez-Munain C, Wang S, Speck NA, Krangel MS. 1992. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol Cell Biol 12:4817-4823.
23. Richkind K, Hromas R, Lytle C, Crenshaw D, Velasco J, Roherty S, Srinivasiah J, Varella-Garcia M. 2000. Identification of two new translocations that disrupt the AML1 gene. Cancer Genet Cytogenet 122: 141-143.
24. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85: 3662-3670.
25. Roulston D, Espinosa R, Nucifora G, Larson RA, Le Beau MM, Rowley JD. 1998. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemia: association with prior therapy. Blood 92:2879-2885.
26. Sacchi N, Nisson PE, Watkins PC, Faustinella F, Wijsman J, Hagemeijer A. 1994. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosomes Cancer 11:226-236.
27. Slovak ML, Bedell V, Popplewell L, Arber DA, Schoch C, Slater R. 2002. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosomes Cancer 33:379-394.
28. Suzow J, Friedman AD. 1993. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol Cell Biol 13:2141-2151.
29. Tahirov TH, Inoue-Bungo T, Morii H, Fujikawa A, Sasaki M, Kimura K, Shiina M, Sato K, Kumasaka T, Yamamoto M, Ishii S, Ogata K. 2001. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBF-beta. Cell 104:755-767.
30. Thieblemont C, Felman P, Callet-Bauchu E, Traverse-Glehen A, Salles G, Berger F, Coiffier B. 2003. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 4:95-103.
31. Uchida H, Zhang J, Nimer SD. 1997. AML1A and AML1B can transactivate the human IL-3 promoter. J Immunol 158:2251-2258.
32. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13:3324-3339.
33. Wargnier A, Legros-Maida S, Bosselut R, Bourge JF, Lafaurie C, Ghysdael CJ, Sasportes M, Paul P. 1995. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci USA 92:6930-6934.
34. Zenklusen JC, Hodges LC, LaCava M, Green ED, Conti CJ. 2000. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene 19:1729-1733.
35. Zent CS, Mathieu C, Claxton DF, Hiebert S, Zhang D-E, Tenen D, Rowley JD, Nucifora G. 1996. The chimeric genes AML1/MDS1 and AML1/EAP repress the CSF1R promoter, but only AML1/MDS1 has tumor promoter properties. Proc Natl Acad Sci USA 93:1044-1048.
36. Zhang DE, Fujioka K, Hetherington CJ, Shapiro LH, Chen HM, Look AT, Tenen DG. 1994. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol 14:8085-8095.
37. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, Le Beau MM, Rowley JD, Diaz MO. 1991. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735-10739.